Cargando…
Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma
Embryonal rhabdomyosarcoma (ERMS) is the most common soft tissue cancer in children. The prognosis of patients with relapsed or metastatic disease remains poor. ERMS genomes show few recurrent mutations, suggesting that other molecular mechanisms such as epigenetic regulation might play a major role...
Autores principales: | Vleeshouwer-Neumann, Terra, Phelps, Michael, Bammler, Theo K., MacDonald, James W., Jenkins, Isaac, Chen, Eleanor Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670218/ https://www.ncbi.nlm.nih.gov/pubmed/26636678 http://dx.doi.org/10.1371/journal.pone.0144320 |
Ejemplares similares
-
Characterization of GRK5 as a novel regulator of rhabdomyosarcoma tumor cell growth and self-renewal
por: Pham, Thao, et al.
Publicado: (2020) -
A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma
por: Selim, Omar, et al.
Publicado: (2023) -
Overactivation of histone deacetylases and EZH2 in Wilms tumorigenesis
por: Chen, Chao-Hui, et al.
Publicado: (2022) -
The histone deacetylase SIRT6, a critical modulator of metabolism and tumorigenesis
por: Sebastian, Carlos, et al.
Publicado: (2012) -
Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer
por: Giannopoulou, Aikaterini F., et al.
Publicado: (2019)